Role of Radiotherapy in Localized Prostate Cancer
- The current AUA/ASTRO consensus guidelines recommend adjuvant RT in postoperative patients with high-risk pathologic features (pT3 or positive margins).
- PSA monitoring could be an alternative; however, early administration of radiation is warranted if there is a sign of progression.
- The prognostic value of preradiation PSA is well established.
- Doses above 65 Gy to the prostate bed are recommended in the postoperative setting.
- The role of pelvic radiation is being investigated; currently, the decision is based on clinical judgment.
- Short-term ADT should be discussed with patients starting postoperative RT.